Multiple types of voltage-dependent Ca 2ϩ channels are involved in the regulation of neurotransmitter release (Tsien et al., 1991; Dunlap et al., 1995) . In the nerve terminals of the neurohypophysis, the roles of L-, N-, and P/Q-type Ca 2ϩ channels in neuropeptide release have been identified previously (Wang et al., 1997a) . Although the L-and N-type Ca 2ϩ currents play equivalent roles in both vasopressin and oxytocin release, the P/Q-type Ca 2ϩ current only regulates vasopressin release. An oxytocin-release and Ca 2ϩ current component is resistant to the L-, N-, and P/Q-type Ca 2ϩ channel blockers but is inhibited by Ni 2ϩ . A new polypeptide toxin, SNX-482, which is a specific ␣ 1E -type Ca 2ϩ channel blocker (Newcomb et al., 1998) , was used to characterize the biophysical properties of this resistant Ca 2ϩ current component and its role in neuropeptide release. This resistant component was dose dependently inhibited by SNX-482, with an IC 50 of 4.1 nM. Furthermore, SNX-482 did not affect the other Ca 2ϩ current types in these CNS terminals. Like the N-and P/Q-type Ca 2ϩ currents, this SNX-482-sensitive transient Ca 2ϩ current is high-threshold activated and shows moderate steady-state inactivation. At the same concentrations, SNX-482 blocked the component of oxytocin, but not of vasopressin, release that was resistant to the other channel blockers, indicating a preferential role for this type of Ca 2ϩ current in oxytocin release from neurohypophysial terminals. Our results suggest that an ␣ 1E or "R"-type Ca 2ϩ channel exists in oxytocinergic nerve terminals and, thus, functions in controlling only oxytocin release from the rat neurohypophysis.
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Voltage-dependent channels are responsible for the Ca 2ϩ that enters nerve terminals and elicits vesicular release of neurotransmitters (Augustine et al., 1987) . Neurotransmitter release in the CNS is regulated by multiple types of C a 2ϩ channels (Dunlap et al., 1995) . A number of studies have defined several electrophysiologically distinct C a 2ϩ channels on neuronal cell bodies: L-, N-, T-, and P-types (Fox et al., 1987; Bean, 1989; Tsien et al., 1991; Llinas et al., 1992) . Other classes of channels, such as the Q-and R-types, have been revealed by molecular cloning (Snutch and Reiner, 1992; Ellinor et al., 1993; Sather et al., 1993; Perez-Reyes et al., 1998) and the use of C a 2ϩ antagonists (Olivera et al., 1984; Hillyard et al., 1992; Ramachandran et al., 1993; Newcomb et al., 1998) . The specific role at C NS terminals of these different types of Ca 2ϩ channels, however, is still unclear. The N-type channel seems to be involved in classical neurotransmission (Hirning et al., 1988) , whereas the L -type is known to regulate the secretion of certain peptides (C azalis et al., 1987; Dunlap et al., 1995) . The class E (␣ 1E ) and G (␣ 1G ) Ca 2ϩ channels have been localized recently to the C NS (Westenbroek et al., 1995; Perez-Reyes et al., 1998) . However, the phenotype of the expressed ␣ 1E channel is controversial (Snutch and Reiner, 1992; Randall and Tsien, 1995) , and the biophysical properties of the class E current in CNS terminals remain to be determined.
To determine any role for class E channels in CNS secretion (see Wu et al., 1998 Wu et al., , 1999 , we studied the nerve terminals of the rat neurohypophysis. This is a population of relatively homogeneous peptidergic nerve endings that allows comparative study by a number of different techniques. This has been a very useful model system for characterization of nerve terminal Ca 2ϩ channels (Lemos and Nowycky, 1989; Wang et al., 1992 Wang et al., , 1997a Wang and Lemos, 1994; Fisher and Bourque, 1995) and of mechanisms underlying depolarization-secretion coupling (Cazalis et al., 1987; Lim et al., 1990; Lindau et al., 1992; Wang et al., 1993b Wang et al., , 1997a Branchaw et al., 1998) . We have shown previously that "L"-and "N"-type Ca 2ϩ channels exist in nerve terminals of the neurohypophysis (Lemos and Nowycky, 1989; Wang et al., 1992) and that they control both vasopressin (AVP) and oxytocin (OT) release, except for a significant resistant component (Cazalis et al., 1987; Dayanithi et al., 1988; Wang et al., 1993b) . More recently we have shown that a "Q"-type Ca 2ϩ current component also exists in approximately one-half of these CNS terminals (Wang et al., 1997a) . Moreover, when blockers of the Q-type Ca 2ϩ current were added to the terminals, the resistant component of AVP release was essentially abolished. In contrast, a similar resistant component of OT release was unchanged by the same concentrations of the Q-type channel blockers.
Most recently we have shown that purified native SNX-482, a specific ␣ 1E channel blocker, could inhibit the neurohypophysial Ca 2ϩ current (Newcomb et al., 1998) . This led us to examine, using a combination of pharmacological and biophysical techniques, whether class E or R-type C a 2ϩ channels might also exist on these C NS terminals and f unctionally contribute to neurosecretion.
MATERIALS AND METHODS
Electrophysiolog ical recordings. As we have described previously (Wang et al., 1997a) , after sedation by C O 2 the rats were killed by decapitation using a guillotine. The neurohypophysis was then excised, following previous protocols, and homogenized in a solution containing (in mM): sucrose, 270; H EPES-Tris, 10; and K-EGTA, 0.01, pH 7.25 (C azalis et al., 1987) . All chemicals were obtained from Sigma (St. L ouis, MO). The isolated neurohypophysial nerve terminals could be identified under an inverted microscope . Normal L ocke's solution [containing (in mM), NaC l, 145; KC l, 5; C aC l 2 , 2.2; MgC l 2 , 1; Na-H EPES, 10; and glucose, 15, pH 7.35] was then used to perf use the terminals. Before patch-clamp recordings, the terminals (usually 5-8 m in diameter) were perf used with the 5 mM Ba 2ϩ (replacing C aC l 2 ) L ocke's solution, which also contained 1 M TTX with 0.02% BSA. To obtain perforated-patch (Rae et al., 1991) recordings in the "wholeterminal" configuration (Hamill et al., 1981) , freshly made amphotericin B (240 -300 g /ml) was mixed with the pipette solution that contained (in mM): C s-glutamate, 135; H EPES, 10; glucose, 5; C aC l 2 , 2; MgCl 2 , 1; and TEA, 20, pH 7.25.
As reported previously (Wang et al., 1997a) , the perforated-patch recording configuration enables us to overcome problems with the rundown of Ca 2ϩ currents that complicated former studies (Lemos and Now ycky, 1989; Wang et al., 1992; Wang and Lemos, 1994; Fisher and Bourque, 1995; Branchaw et al., 1998) . Only terminals with perforatedpatch access resistances of Ͻ10 M⍀ were chosen for f urther recordings. The Ba 2ϩ current (I Ba ), which was activated by depolarizing from Ϫ80 to ϩ10 mV and demonstrated both transient and long-lasting components (see, e.g., Fig. 1A ), could be maintained for Ͼ1 hr without appreciable rundown. The I Ba was filtered at 3 kHz and sampled at 10 kHz. pC lamp (Axon Instruments, Burlingame, CA) was used for acquisition and analysis of data.
Peptide release. Rat neurohypophyses (see Electrophysiological recordings) were homogenized as described previously (C azalis et al., 1987) . The homogenate was centrif uged at 2400 ϫ g for 6 min. The resulting pellet contains highly purified nerve terminals. The nerve endings were loaded onto filters (0.45 m Acro disk; Gelman Sciences, Ann Arbor, M I) and perf used at 37°C with normal L ocke's solution. Four minute fractions of perf usate were collected, and the evoked release was triggered by an 8-min-duration pulse of a depolarizing concentration (50 mM) of K ϩ . The results are given as AV P or OT release per fraction using specific radioimmunoassays (Wang et al., 1997a) . The medium before and after the depolarizing period contained (in mM): NaC l, 40; KHCO 3 , 5; N-methyl-D-glucamine (NMG)-C l, 100; MgC l 2 , 1; CaCl 2 , 2; glucose, 10; and Tris-H EPES, 10, with 0.02% BSA, pH 7.25. Depolarization medium contained 50 mM K ϩ , in which the NMG was reduced to maintain the osmolarity (300 -310 mOsm).
Pol ypeptide toxins. The polypeptide toxins used in this study were synthetic versions prepared by Neurex Pharmaceutical Corporation (Ramachandran et al., 1993) . These were termed SN X-482, the synthetic version of a novel 41 amino acid peptide isolated from the venom of the West African tarantula Hysterocrates g igas (Newcomb et al., 1998) , SN X-111, the synthetic version of -conopeptide M V IIA (Olivera et al., 1994) , SN X-194, the methionine-12 to norleucin-12 derivative of SN X-111, and SN X-230, the synthetic version of M V IIC (Hillyard et al., 1992) . The synthetic version of -AgaIVA was purchased from Peptides International (L ouisville, K Y) or synthesized as described by Gaur et al., (1994) . In the text we refer to the synthetic peptides by their original names or by the Neurex terms.
Data anal ysis. All results are given as means Ϯ SEM, and the statistical significance of differences in groups was analyzed using SigmaStat (Jandel Scientific, San Rafael, CA) with T ukey's t tests.
RESULTS

Ca 2؉ channel currents
In the isolated neurohypophysial terminals, the peak I Ba , which was activated by depolarizing from Ϫ80 to ϩ10 mV, demonstrates both transient and long-lasting components ( Fig. 1 A) . As we have reported previously (Wang et al., 1997a) , the use of the dihydropyridine (DHP) Ca 2ϩ channel antagonist nicardipine (2.5 M) selectively inhibits the long-lasting (L-) component of the Ba 2ϩ currents (Fig. 1 ). Subsequent addition of the N-type Ca 2ϩ channel blocker MVIIA (3000 nM) led to rapid inhibition of a large portion of the isolated transient component (and, to a lesser extent, the long-lasting component) of the Ba 2ϩ current. This concentration has been shown previously to block the N-type component maximally (Wang et al., 1997a) .
In ϳ50% of the neurohypophysial terminals investigated, subsequent addition of low (36 nM) concentrations of MVIIC inhibited this remaining component, and higher (150 nM) concentrations almost completely abolished it (Wang et al., 1997a) . In another group of terminals (ϳ46%), however, the non-L-and -N-types of Ca 2ϩ currents could not be blocked by the P/Q-type Ca 2ϩ channel blockers MVIIC or AgaIVA (Fig. 1 ). This resistant part of the transient Ca 2ϩ current appeared to be analogous to an R-type Ca 2ϩ channel current (Randall and Tsien, 1995) .
Pharmacology of resistant Ca 2؉ channel currents
To test whether this resistant component of the Ba 2ϩ current could indeed be classified as an R-type Ca 2ϩ channel current, Ni 2ϩ , a T-and R-type Ca 2ϩ channel blocker, was applied to this terminal. Low concentrations (86M) of Ni 2ϩ inhibited the resistant current (Fig. 1) . Because of the low selectivity of Ni 2ϩ between Ca 2ϩ channels, however, the identity of the resistant component of the Ca 2ϩ current in the nerve terminal was still unclear.
A newly discovered polypeptide toxin, SNX-482, was found to be a specific blocker of the class E (␣ 1E ) Ca 2ϩ channel (Newcomb et al., 1998 ). This toxin made it possible for us to identify the Ni 2ϩ -sensitive type of Ca 2ϩ current and to probe its function in neurohypophysial nerve terminals (Wang et al., 1997b; Dayanithi et al., 1999) . First, the effects of SN X-482 on the long-lasting and transient components of the Ba 2ϩ current of the neurohypophysial terminals were examined (Fig. 2 A) . The isolated, transient component of the Ba 2ϩ current usually includes an N-type and either a P/Q-type or a resistant component of C a 2ϩ channel currents (Wang et al., 1997a) . The IC 50 for the undifferentiated transient I Ba , obtained from the equation (Fig. 2 B) . This is similar to that for SN X-482 to inhibit the cloned ␣ 1B (N-type) C a 2ϩ channel current but much higher than that (IC 50 ϭ 10 nM) to block the heterologously expressed ␣ 1E -type currents (Newcomb et al., 1998) . The toxin does not affect the DHP-sensitive or L-type current in these terminals. These results indicate that, at high concentrations, SNX-482 could block some combination of N-, P/Q-, and/or class E-type Ca 2ϩ channels in the terminals.
Application of a combination of DHP, MVIIA, and MVIIC or of high concentrations of MVIIA/SNX-194 and MVIIC/ AgaIVA allowed us to obtain isolated "resistant" Ba 2ϩ or Ca 2ϩ currents (Fig. 3A) . SNX-482, in a dose-dependent manner (in a total of seven terminals), inhibited the isolated resistant currents (Fig. 3A,B) with an IC 50 of 4.1 nM (Fig. 3C ), similar to that found for the ␣ 1E Ca 2ϩ currents expressed in human embryonic kidney (HEK) cells (Newcomb et al., 1998) . The inhibition by SNX-482 of the resistant-type Ba 2ϩ current is reversible (Fig. 3D) . Furthermore, both SNX-482 and Ni 2ϩ inhibited the same previously resistant component of the Ba 2ϩ current (Fig. 3D ). Any sensitivity of P/Q-type currents in the nerve terminals to SNX-482 was then examined. As shown in Figure 4 A, in the presence of the L-type blocker nicardipine and the N-type blocker MVIIA, the remaining Ba 2ϩ component was not affected by SNX-482, although it was inhibited by the P/Q-type blocker AgaIVA. This confirmed that SNX-482 is not a P/Q-type or class A channel blocker (Newcomb et al., 1998) . The inhibition of the resistant Ba 2ϩ current component, in ϳ46% of the neurohypophysial terminals investigated, by both Ni 2ϩ and SNX-482 lead us to conclude that this channel current most closely resembles that of the ␣ 1E Ca 2ϩ channel subunit expressed in HEK cells (Newcomb et al., 1998) .
Interestingly, in ϳ5% of the terminals investigated (n ϭ 21), in addition to the L-and N-type Ca 2ϩ channel currents, there appears to exist both P/Q-and SNX-482-sensitive-type Ba currents. Figure 4 B is an example of this, showing that the non-Land non-N-type Ba 2ϩ currents were partially sensitive to both SNX-482 and AgaIVA.
Biophysical properties
Biophysical characterization of the resistant component of the neurohypophysial terminal I Ba also favors a class E or R-type Ca 2ϩ channel classification. This component of the current is a transient, high-voltage-activated Ba 2ϩ current with an inactivation rate constant of 21 Ϯ 3 msec (n ϭ 7) during a step to 0 mV (see Fig. 3A ). Figure 5A illustrates the activation (V 1/2 ϭ Ϫ14.2 mV) and steady-state inactivation (V 1/2 ϭ Ϫ58.8 mV) of the SNX-482-sensitive component of the neurohypophysial terminal Ba 2ϩ current. The inactivating rate constant and activation and steady-state inactivation curves (Fig. 5A ) of this neurohypophysial C a 2ϩ current component are most consistent with those of the R-type C a 2ϩ channel in granule cells (Randall and Tsien, 1995) . Nevertheless, the other transient C a 2ϩ current components (N-and P/Q-type) appear to have biophysical properties similar to those of this "R"-type C a 2ϩ component (Wang et al., 1997a) .
The relative permeabilities for C a 2ϩ versus Ba 2ϩ between the total channel currents and the isolated SN X-482-sensitive or R-type current were compared, as shown in Figure 5B . Ba 2ϩ currents were significantly larger than the corresponding Ca 2ϩ currents for both the total and the isolated components. The inactivation rate constant, however, differed. The total current showed slower inactivation with Ba 2ϩ as compared with Ca 2ϩ as the charge carrier, whereas the R-type currents showed no difference in their inactivation with either Ba 2ϩ or C a 2ϩ .
Peptide release
In a previous report (Wang et al., 1997a) , we found that a significant portion of OT release could not be inhibited even by simultaneous applications of L -, N-, and P/Q-type C a 2ϩ channel blockers. To determine whether the class E or R-type Ca 2ϩ channel could play a role in this secretion, we measured both OT and AV P release in the same samples collected from perfused populations of nerve terminals (Fig. 6) . Capitalizing on the same pharmacological protocol used to isolate the R-type component electrophysiologically (see Fig. 3A ), we revealed a similar resistant component (42.3%) of Ca 2ϩ -dependent OT release (Fig.  6 B) . In these experiments, high K ϩ alone induced OT release of 4258 Ϯ 306 pg (n ϭ 4), and both nicardipine and MVIIA, given in combination, reduced (by 57.7 Ϯ 3.8%) high-K ϩ -stimulated release to 1812 Ϯ 376 pg. SNX-482 (20 nM) completely blocked the remaining stimulated OT release (to basal level, 159 Ϯ 33 pg). In contrast, a similar resistant component (38.4%) of stimulated AVP release (406 Ϯ 30 pg) was essentially unchanged (458 Ϯ 63 pg; n ϭ 4) by the same concentration of this R-type channel blocker (Fig. 6 A) . As shown previously (Wang et al., 1997a) , this resistant component of AVP release was blocked (to basal level, 60 Ϯ 3 pg) by the P/Q-type blocker MVIIC. These results were the same even if the order of drugs was reversed or scrambled (data not shown). Furthermore, stimulated release was stable during prolonged applications of each of the Ca 2ϩ channel blockers, indicating that steady-state effects had been established.
We have also performed a set of experiments to compare quantitatively the SNX-482 block of OT release with the IC 50 of this toxin on R-type calcium channels. As described in the Figure  6 legend, the nerve terminals were challenged with 50 mM K ϩ either in the absence of any channel blocker (control) or in the presence of both 2.5 M nicardipine (L-type channel blocker) and 1 M MVIIA (N-type channel blocker) and then subsequently with varying concentrations of 5, 10, 20, 50, or 100 nM) . In this batch of experiments, K ϩ alone evoked 3678 Ϯ 139 . SN X-482 (40 nM) did not affect the remaining Ba 2ϩ current, which was subsequently blocked by the P/Q-type blocker AgaIVA (450 nM). B, By the use of the same protocol described in A, SN X-482 and AgaIVA each had a partial effect on the non-L and non-N-type Ba 2ϩ current in a different nerve terminal. Therefore, some (ϳ5%) neurohypophysial terminals have both P/Q-and R-type currents. Figure 5 . Voltage dependence and kinetics of Ba 2ϩ and Ca 2ϩ currents in neurohypophysial terminals. A, Activation (F) and steady-state inactivation (E) curves for the pharmacologically isolated (see Fig. 1 ) R-type macroscopic Ba 2ϩ currents are illustrated (n ϭ 3). The peak Ba 2ϩ currents elicited were normalized to the maximal currents (for the steadystate inactivation curve) or conductances (for the activation curve) and plotted versus the holding potentials or the step potentials, respectively. Data for activation and steady-state inactivation were fit using appropriate forms of the Boltzmann equation. For activation,
, and for steady-state inactivation,
, where C is the conductance at a given voltage, C max is the maximum conductance, I is the current amplitude at a given voltage, I max is the maximum current, V s is the voltage step, V 1/2 is the midpoint potential, and k is the slope parameter. The fitting of the two curves for the isolated resistant (R)-type I Ba gives V 1/2 values of Ϫ14.1 mV (k ϭ 5.0) and Ϫ58.8 mV (k ϭ 5.7) for activation and inactivation, respectively. B, Comparison of amplitudes and inactivation rates of the total versus R-type C a 2ϩ and Ba 2ϩ currents is shown. Bottom histograms, The 5 mM Ba 2ϩ total currents (n ϭ 5) and the isolated R-type Ba 2ϩ currents (n ϭ 4) were larger than the 5 mM Ca 2ϩ total currents (n ϭ 5) and isolated R-type C a 2ϩ currents (n ϭ 3), respectively ( p Ͻ 0.01). Top histograms, The inactivation time constant () was obtained from the same groups of terminals (as above). The 5 mM Ba 2ϩ total currents had larger values, or slower inactivation, than did the 5 mM Ca 2ϩ current group ( p Ͻ 0.01). The R-type Ba 2ϩ currents, however, had values similar to those of the R-type C a 2ϩ currents ( p Ͼ 0.05).
pg (n ϭ 3). L -and N-type channel blockers reduced this OT release by 59.7% (to 2194 Ϯ 100 pg). Further addition of 1, 5, 10, 20, 50, or 100 nM SN X-482 suppressed the resistant OT release by 8% (to 2018 Ϯ 30 pg), 32.6% (to 1478 Ϯ 54 pg), 61.4% (to 846 Ϯ 40 pg), 93.4% (to 145 Ϯ 7 pg), 95.6% (to 96 Ϯ 6 pg), and 97.6% (to 52 Ϯ 6 pg), respectively. The IC 50 calculated from the equation r ϭ R max {1 Ϫ [x/(IC 50 ϩ x)]} for the SN X-482 block of OT release is 6.8 nM, which is comparable with the IC 50 for the toxin on R-type calcium currents. Finally, the effects of SNX-482 on OT versus AV P release were significantly ( p Ͻ .001) different, thus revealing the importance of the class E or R-type component in only OT release.
DISCUSSION
The isolated neurohypophysial terminals are uniquely useful for studying the pharmacological, biophysical, and functional properties of Ca 2ϩ channels at the site of secretion, and they have revealed a surprising pharmacological and functional complexity in the CNS presynaptic Ca 2ϩ channel family.
Four different components of Ca 2؉ -dependent neuropeptide release
The regulation of neurotransmission in the mammalian CNS has been characterized by the involvement of multiple types of voltage-dependent Ca 2ϩ channels, each of which might play a specific role in the regulation of neurotransmission. In the mammalian neurohypophysial system, the L-and N-type Ca 2ϩ channels play an equivalent role in both AVP and OT release. This is quite different from the role of Ca 2ϩ channels in classical neurotransmission, in which the N-and P/Q-type, instead of the L-type, Ca 2ϩ channel current are dominant in controlling neurotransmitter release (Hirning et al., 1988; Wheeler et al., 1994; Dunlap et al., 1995) . Furthermore, the P/Q-type Ca 2ϩ channel has turned out to be critical for AVP release from neurohypophysial nerve terminals (Wang et al., 1997a) . Finally, the present results have demonstrated that an SNX-482-sensitive Ca 2ϩ current is responsible for an important part of OT release.
Identity of the resistant Ca 2؉ channel in nerve terminals
We have now shown that the SNX-482-sensitive Ca 2ϩ current has similar biophysical properties to that of the class E channel. The phenotype of the expressed class E channel (Zhang et al., 1993) can resemble that of native currents described as either R- (Randall and Tsien, 1995) or T-type (Snutch and Reiner, 1992) . The T-type Ca 2ϩ channel in the CNS is a low-voltage-activated channel that is affected by Ni 2ϩ (Tsien et al., 1991; Fisher and Bourque, 1996) . The terminal SNX-482-sensitive Ca 2ϩ current, although also blocked by Ni 2ϩ , is moderately high voltage activated and more permeable to Ba 2ϩ than to Ca 2ϩ (Fig. 5B) . Thus, in terms of its biophysical properties, this channel appears to be different from the T-type Ca 2ϩ channel. A correspondence between cloned expressed class E calcium channels and various currents described as resistant, or R-type, is suggested by similar electrophysiological properties and resistance to selective antagonists of N, P/Q, and L-type calcium channels (Newcomb et al., 1998) . In the absence of a selective antagonist of the class E calcium channel, however, the correspondence between calcium channel classes defined by cDNA sequencing and electrophysiology has been unclear, and the role of class E calcium channels in physiology has not been studied previously (but see Wu et al., 1998 Wu et al., , 1999 . Our study capitalizes on the recent discovery of a selective class E antagonist from tarantula venom, SNX-482, and it has allowed us to analyze directly the identity, function, and pharmacology of the resistanttype calcium channels in CNS terminals.
The initial studies of the in vitro actions of native SNX-482 have revealed unanticipated diversity in the response of native R-type currents to the peptide (Newcomb et al., 1998) . Nevertheless, because low nanomolar concentrations of SNX-482 have no effects on other calcium channel subtypes (see Figs. 2, 4) (Newcomb et al., 1998) , the potent block of the neurohypophysial R-type current demonstrates that the resistant current isolated pharmacologically is not simply residual current flowing through incompletely blocked N-, P/Q-, and L-type calcium channels. Thus, the Figure 6 . Effects of the C a 2ϩ channel blocker SN X-482 on AV P versus OT release from nerve terminals. A, AV P release was repeatedly stimulated (see arrows) with 50 mM K ϩ . The isolated neurohypophysial terminals were challenged with elevated K ϩ either in the absence ( first arrow) of any channel blockers or in the presence of 2.5 M nicardipine (L -type Ca 2ϩ channel blocker) and 1 M MVIIA (N-type Ca 2ϩ channel blocker) and then subsequently with the addition of 20 nM SN X-482 (R-type C a 2ϩ channel blocker) and finally plus 300 nM M V IIC (P/Q-type C a 2ϩ channel blocker). All these drugs were present for at least 20 min before, during, and after the K ϩ stimulation (see differentl y shaded horizontal bars above). The inhibitions were mostly reversible, as indicated by control K ϩ stimulation after washout (last arrow). All data points represent the mean of four to six experiments. B, OT release was repeatedly stimulated with 50 mM K ϩ . The nerve terminals were challenged with elevated K ϩ either in the absence ( first arrow) of any channel blockers or in the presence of 2.5 M nicardipine (L) and 1 M M V IIA (N), then 20 nM SN X-482 (R), and finally 300 nM MVIIC (P/Q) (see horizontal bars above). This inhibition was also mostly reversible (last arrow). Note that the same perf usate samples were assayed for both OT and AV P.
variability of the response of native R-type currents almost certainly indicates pharmacological heterogeneity of the distinct entities, perhaps splice variants, which are responsible for these currents.
These variants could also explain the fact that class E mRNA has, so far, not been detected in the hypothalamic magnocellular somata that project to the neurohypophysis (Gainer and Chin, 1998) . In contrast, preliminary evidence (G. Dayanithi, unpublished results), using antibodies raised against class E channels, has localized these channels to isolated neurohypophysial terminals.
The R-type Ca 2؉ channel controls OT, but not AVP, release
Our data suggest that in one group of terminals, there is a Ni 2ϩ -and SN X-482-sensitive C a 2ϩ channel able to regulate OT release preferentially, whereas in another group of terminals the P/Qtype Ca 2ϩ channel plays a converse role in AV P release. We demonstrate here that the ␣ 1E class or R-type C a 2ϩ channel exists on these neurohypophysial terminals, where it participates in the control of neuropeptide secretion. These results lead to the hypothesis that the R-type channels are preferentially localized on OT peptide-containing nerve terminals and thus do not affect Ca 2ϩ currents in vasopressinergic terminals. Interestingly, some (5%) terminals appear to have both types of channels (Fig. 4 B) , comparable with the observed percentage of terminals containing both OT and AV P (Wang et al., 1997b) . In any case, the data clearly show that the R-type component plays an important role in OT, but not in AV P, secretion from these C NS terminals.
In conclusion, we have demonstrated that an R-type Ca 2ϩ channel exists in at least one type of C NS terminal and is important in depolarization -secretion coupling. This lends support to the idea that R-type channels may play a specific role in synaptic transmission in other C NS synapses (Newcomb et al., 1998; Wu et al., 1998 Wu et al., , 1999 . The data presented here clarify the specific identities and f unctional importance of the C a 2ϩ channels actually located at nerve terminals and point out that the Rand P/Q-channels, at least, may be heterogeneously localized for different f unctions.
